Patient Satisfaction With the Management of a Stopped Pregnancy in the First Trimester

University Hospital, Toulouse52 enrolled

Overview

The clinical practice recommendations highlight the fact that the patient's choice concerning the management of her aborted pregnancy in the first trimester should be privileged, after clear and appropriate information on the available treatments, in order to improve his experience and reduce the negative psychological symptoms that can generate an alteration in the quality of life, in the aftermath of the loss of pregnancy. The present study will describe the efficacy, satisfaction and tolerance of patients benefiting from medical treatment with Mifégyne® and MisoOne® versus those benefiting from surgical treatment by endo-uterine aspiration for the management of a pregnancy stopped during the first trimester at the Toulouse University Hospital

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Pregnancy Loss, Early

Interventions

When participants arrive for their uterine emptiness check-up, 12 days after treatment, patients will be asked to drop off the study questionnaire the same day in a box provided for this purpose in the department.

Endo-uterine aspirationPROCEDURE

When patients arrive in hospital on the day of the surgery, participants will be asked to complete a questionnaire at home 1 week after surgery and return it to investigators.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Any adult patient presenting to the gynecological emergency department of the Paule de Viguier Hospital in Toulouse for whom a diagnosis of an arrested pregnancy in the first trimester is made * Whose cranio-caudal length of the embryo measured by ultrasound is less than 25 mm or having a clear egg * Having agreed to the study (written or verbal) after clear and fair information * Who understands and reads French Exclusion Criteria: * Medical contraindication to treatment with Mifégyne® or MisoOne® * Hemodynamically unstable patient requiring urgent surgical treatment. * Protected adult patient (guardianship, curatorship, safeguard of justice)

Locations (1)

Mickael ALLOUCHE

Toulouse, France

Outcomes

Primary Outcomes

Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

Time frame: Inclusion day (day 0)

Patient satisfaction

Completing the satisfaction questionnaire

Time frame: Inclusion day (day 0)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.